REFRACTORY CHILDHOOD ACUTE MYELOID LEUKEMIA
Clinical trials for REFRACTORY CHILDHOOD ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY CHILDHOOD ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for REFRACTORY CHILDHOOD ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with relapsed leukemia: experimental drug combo enters trial
Disease control Recruiting nowThis early-stage trial tests a new drug called imetelstat combined with two standard chemotherapies for children and teens with acute myeloid leukemia, myelodysplastic syndrome, or juvenile myelomonocytic leukemia that has returned or not responded to treatment. The main goal is …
Matched conditions: REFRACTORY CHILDHOOD ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Experimental CAR t therapy targets tough childhood leukemia
Disease control Recruiting nowThis early-phase trial is testing a new type of immune cell therapy called FOLR1 CAR T cells for children aged 6 and under with acute myeloid leukemia (AML) that has come back or not responded to treatment. The therapy involves taking a child's own immune cells, modifying them in…
Matched conditions: REFRACTORY CHILDHOOD ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC